Wealthcare Advisory Partners’s Vaxart VXRT Stock Holding History

Wealthcare Advisory Partners’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$1K	–	1853
2021 Q1	$1K	Buy	+100	New	+$769	﹤0.01%	2027

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wealthcare Advisory Partners's VXRT Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 100 shares — an estimated $1K sold.

Wealthcare Advisory Partners first reported a position in VXRT in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 100 Vaxart shares in Q2 2021, an estimated $1K.
Wealthcare Advisory Partners first reported a position in Vaxart in Q1 2021 and held it in 1 quarter.
Wealthcare Advisory Partners's Vaxart position peaked at $1K in Q1 2021.
143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.